# Gansu New Silk Road Industrial Investment

> Gansu New Silk Road Industrial Investment is a VC fund backing Health Care and Biotechnology. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Lanzhou, China
- Total investments: 3
- Last investment: Oct 2021
- Lead investor: 0%
- Last updated: Aug 2026

Gansu New Silk Road Industrial Investment is an investment holding company.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| Biotechnology | 2 | 67% |
| Pharmaceutical | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 33% |
| Series C | 1 | 33% |
| Venture - Series Unknown | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Leads Biolabs | Leads Biolabs is a pharmaceutical company that develops medicines and treatments for tumors. | $100M | Series C | Oct 08, 2021 | http://www.leadsbiolabs.com/ |
| Leads Biolabs | Leads Biolabs is a pharmaceutical company that develops medicines and treatments for tumors. |  | Venture - Series Unknown | Oct 28, 2020 | http://www.leadsbiolabs.com/ |
| Hrain Biotechnology | Hrain Biotechnology is a tumor immunotherapy technology developer, using the tumor immunotherapy technology CAR-T to provide cancer patients with precise treatment based on biological and cellular technology, and built centers in Beijing, Jiangsu, Chongqing, Henan and other places. Clinical trial platform. | $29.3M | Series B | Sep 09, 2020 | http://www.dashengbio.com/ |

3 of 3 investments shown.

## Co-investors
- Enran Chuangtou — VC Fund, 2 deals together
- [Huaige Capital](https://shizune.co/investors/profile/huaige-capital) — VC Fund, 2 deals together
- [Anjie Zhengjuan](https://shizune.co/investors/profile/anjie-zhengjuan) — VC Fund, 1 deal together
- [Beijing Hankang Chuangye Touzi](https://shizune.co/investors/profile/beijing-hankang-chuangye-touzi) — VC Fund, 1 deal together
- [Dyee Capital](https://shizune.co/investors/profile/dyee-capital) — VC Fund, 1 deal together
- Guohong Chuangtou — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Gansu New Silk Road Industrial Investment invest in?

Gansu New Silk Road Industrial Investment invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Series B and Series C stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Gansu New Silk Road Industrial Investment last invest?

The most recent investment recorded for Gansu New Silk Road Industrial Investment closed in Oct 2021. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co